Short-term intensive insulin therapy in insulin-requiring diabetes: Effectiveness and factors predicting success

Diabetes and Metabolism

Volumn 23, Issue 1, 1997, Pages 75-79

  Meyer, L ^a   Grulet, H ^b   Guerci, B ^a   Gross, A ^b   Durlach, V ^b   Leutenegger, M ^b  

^a Ctr Hospitalier Univ de Nancy   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

insulin tolerance test; insulin requiring diabetes; temporary intensive insulin therapy

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0031038769     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Leutenegger M, Gross A, Ostermann G, Grulet H, Pasqual C, Dijoux B. Le diabète insulinorequérant. Diabete Metab, 1988, 14, 463-470.
2. De Fronzo RA. The triumvirate : B cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 1988, 31, 667-687.
3. Roneti L, Schulman GJ, Zawalich W, De Fronzo RA. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest, 1987, 80, 1037-1064.
4. Yki-Järvinen H, Kauppila M, Kujansuu E et al. Comparison of insulin regimens in patients with non- insulin-dependent diabetes mellitus. N Engl J Med, 1992, 327, 1426-1433.
5. Grulet H, Durlach V, Hecart AC, Gross A, Leutenegger M. Study of the rate of early glucose disappearance following insulin injection : insulin sensitivity index. Diabetes Res Clin Pract, 1993, 20, 201-207.
6. Skyler JS, Seigler DE, Reeves ML. Optimizing pumped insulin delivery. Diabetes Care, 1982, 2, 135-139.
7. Scarlett JA, Gray RS, Griffin J, Olefskl JM, Kolterman OG. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care, 1982, 5, 353-363.
8. Gormley MJJ, Hadden DR, Woods R, Sheridan B, Andrews WJ. One-month insulin treatment of type II diabetes : the early and medium-term effects following insulin withdrawal. Metabolism, 1986, 35, 1029-36.
9. Andrews WJ, Vasquez B, Nagulespan M et al. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes, 1984, 33, 634-642.
10. Garvez WT, Olefski JM, Griffin J, Hamman RF, Kolterman OG. The effect of insulin treatment on insulin action and insulin secretion in type II diabetes mellitus. Diabetes, 1985, 34, 222-234.
11. Foley JE, Kashiwagi A, Verso MA, Reaven G, Andrews J. Improvement on in vitro insulin action after one month of insulin therapy in obese non-insulin-dependent diabetics. J Clin Invest, 1983, 72, 1901-09.
12. Dorner M, Pinget M, Brogard SM et al., L'histoire naturelle du diabète, ses rapports avec les troubles de la fonction insulinique. In : « Journées de Diabétologie, Hôtel Dieu », 1984, Paris, Flammarion Médecine Sciences, 51-70.
13. Augustin-Pascalis I, Richard JC, Rodier M, Orsetti A, Mirouze J. Echec secondaire des antidiabétiques oraux : intérêt des infusions insuliniques intra-veineuses. Diabete Metab, 1986, 12, 1-5.
14. Decondavenne B, Kerlo-Gillard V, Fontaine P, et al.. Suivi sur 3 mois de la glycorégulation et de l'insulinosécrétion de 21 DIN après une insulinothérapie par pompe de 7 jours. Diabete Metab, 1987, 13, 771.
15. Vaillant-Piard G, Famier M, Caillet ML et al. Rémission de l'insulinorequérance dans le DNID par infusion insulinique continue intraveineuse transitoire : recherche de critères prédictifs du succès. Diabete Metab, 1987, 13, 772.
16. Brun JM, Vaillant G, Farnier M, Verges B. Intérêt d'une insulinothérapie transitoire chez le diabétique non insulinodépendant échappant au contrôle par les antidiabétiques oraux. Méd Nutr, 1989, 25, 11-16.
17. Grulet H, Gross A, Pasqual C, Durlach V, Leutenegger M. Remission of insulin requirement in late secondary failure to oral hypoglycemic agents (IRD) : results at 24 months and analysis of predictive factors. Diabetes Res Clin Pract, 1991, 13, 189-198.
18. Bonora Moghetti P, Zancanaro C et al.. Estimates of in vivo insulin in man : comparison of insulin tolerance test with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab, 1989, 68, 374-378.
19. Gelding SV, Robinson S, Lowe S, Niththyananthan WH, Johnson DG. Validation of the low-dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol, 1994, 40, 611-615.